[Fluvoxamine and serotonin syndrome in a patient with Parkinson disease].
Le Cavorzin
P
P
Sarkis
S
S
Bénéton
C
C
Pinel
J F
JF
Maruelle
L
L
Le Vaou
P
P
Allain
H
H
D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D003221:Confusion / Q000139:chemically induced*; D003967:Diarrhea / Q000139:chemically induced; D016666:Fluvoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D010300:Parkinson Disease / Q000150:complications*; D011985:Receptors, Serotonin / Q000187:drug effects*; D013577:Syndrome; D014202:Tremor / Q000139:chemically induced
D018687:Antidepressive Agents, Second-Generation; D011985:Receptors, Serotonin; D016666:Fluvoxamine
Fluvoxamine et syndrome sérotoninergique chez un malade parkinsonien.